Adenoviral vectors for gene transfer
References (80)
Group C adenoviruses as vectors for gene therapy
- et al.
Molecular characterization of replication-competent variants of adenovirus vectors and genome modifications to prevent their occurrence
J Virol
(1996) - et al.
Isolation and characterization of packaging cell lines that coexpress the adenovirus E1, DNA polymerase, and preterminal proteins: implications for gene therapy
Gene Ther
(1997) - et al.
Long-term gene delivery into the liver of immunocompetent mice with E1/E4-defective adenoviruses
J Virol
(1997) - et al.
‘Sero-switch’ adenovirus-mediated in vivo gene transfer: circumvention of anti-adenovirus humoral immune defenses against repeat adenovirus vector administration by changing the adenovirus serotype
Hum Gene Ther
(1996) Transfer of genes to humans: early lessons and obstacles to success
Science
(1995)Replicating vectors for gene therapy of cancer: risks, limitations and prospects
Eur J Cancer
(1994)- et al.
Studies on the use of viruses in the treatment of carcinoma of the cervix
Cancer
(1956)
An adenovirus mutant that replicates selectively in p53-deficient human tumor cells
Science
(1996)
Adenovirus proteins from both E1B reading frames are required for transformation of rodent cells by viral infection and DNA transfections
Virology
(1987)
Development of cell lines capable of complementing E1, E4, and protein IX defective adenovirus type 5 mutants
Hum Gene Ther
(1995)
Efficient dual transcomplementation of adenovirus E1 and E4 regions from a 293-derived cell line expressing a minimal E4 functional unit
J Virol
(1996)
A gene transfer vector-cell line system for complete functional complementation of adenovirus early regions E1 and E4
J Virol
(1996)
Biology of adenovirus vectors with E1 and E4 deletions for liver-directed gene therapy
J Virol
(1996)
Elimination of both E1 and E2a from adenovirus vectors further improves prospects for in vivo human gene therapy
J Virol
(1996)
Development of a complementing cell line and a system for construction of adenovirus vectors with E1 and E2a deleted
J Virol
(1996)
293 cell lines that inducibly express high levels of adenovirus type 5 precursor terminal protein
Virology
(1996)
Characterization of a replication-incompetent adenovirus type 5 mutant deleted for the preterminal protein gene
Proc Natl Acad Sci USA
(1996)
Improved adenovirus packaging cell lines to support the growth of replication-defective gene-delivery vectors
Proc Natl Acad Sci USA
(1996)
Prolonged transgene expression in cotton rat lung with recombinant adenoviruses defective in E2a
Hum Gene Ther
(1994)
Ablation of E2A in recombinant adenoviruses improves transgene persistence and decreases inflammatory response in mouse liver
Proc Natl Acad Sci USA
(1994)
Cellular immunity to viral antigens limits E1-deleted adenoviruses for gene therapy
Proc Natl Acad Sci USA
(1994)
Inactivation of E2a in recombinant adenoviruses improves the prospect for gene therapy in cystic fibrosis
Nat Genet
(1994)
Prolonged metabolic correction in adult ornithine transcarbamylase-deficient mice with adenoviral vectors
J Biol Chem
(1996)
Lack of persistence of E1- recombinant adenoviral vectors containing a temperature-sensitive E2A mutation in immunocompetent mice and hemophilia B dogs
Gene Ther
(1996)
Isolation and analysis of adenovirus type 5 mutants containing deletions in the gene encoding the DNA-binding protein
J Virol
(1985)
Characterization of factors involved in modulating persistence of transgene expression from recombinant adenovirus in the mouse lung
Hum Gene Ther
(1997)
Effect of the E4 region on the persistence of transgene expression from adenovirus vectors
J Virol
(1997)
A new adenoviral vector: replacement of all viral coding sequences with 28 kb of DNA independently expressing both full-length dystrophin and β-galactosidase
Proc Natl Acad Sci USA
(1996)
A helper-dependent adenovirus vector system: removal of helper virus by Cre-mediated excision of the viral packaging signal.
Proc Natl Acad Sci USA
(1996)
Recombinant adenoviruses with large deletions generated by cre-mediated excision exhibit differential biological properties compared with first-generation vectors in vitro and in vivo
J Virol
(1996)
Construction of adenovirus vectors through Cre-lox recombination
J Virol
(1997)
Persistence in muscle of an adenoviral vector that lacks all viral genes
Proc Natl Acad Sci USA
(1997)
Role of early region 3 (E3) in pathogenesis of adenovirus disease
Proc Natl Acad Sci USA
(1989)
Role of early genes in pathogenesis of adenovirus pneumonia
Proc Natl Acad Sci USA
(1990)
A mouse model for investigating the molecular pathogenesis of adenovirus pneumonia
Proc Natl Acad Sci USA
(1991)
Safety of adenovirus-mediated transfer of the human cystic fibrosis transmembrane conductance regulatory cDNA to the lungs of nonhuman primates
Hum Gene Ther
(1996)
Pulmonary inflammation induced by incomplete or inactivated adenoviral particles
Hum Gene Ther
(1995)
Cited by (184)
Adenoviral Vector Construction II: Bacterial Systems
2016, Adenoviral Vectors for Gene Therapy: Second Edition
Copyright © 1997 Published by Elsevier Ltd.